PCV2 vaccines
This article describes the main characteristics of commercial vaccines to combat swine circovirosis.
Welcome to 333
Connect, share, and interact with the largest community of professionals in the swine industry.
Celebrating 203,876Users on 333!
Sign up Already a member?Porcine circovirus is caused by porcine circovirus type 2 (PCV2) and has a huge economical impact. Clinically it is presented as a disease which deteriorates animals from the weaning to the finishing period producing a high mortality rate. It also causes dermatitis and nephropathia with high mortality.
Porcine circovirus is caused by porcine circovirus type 2 (PCV2). Clinically it is presented as a disease which deteriorates animals from the weaning to the finishing period producing a high mortality rate. The virus is ubiquitous globally. It is very small and very resistant to the environment. There are two serotypes: Type 1, which does not cause any known disease, and Type 2, which causes disease in pigs. Although the PCV2 has been present in pigs for several years without any clinical manifestation, a mutation or an introduction of a new strain caused a deterioration syndrome with high mortality. There are several different strains (PCV2a, PCV2b, PCV2c, etc.), although vaccines that have the first known strains seem to give adequate protection against all the strains.
A special sign of PCV2 is the dermatitis and nephropathy porcine syndrome. This syndrome appears mainly in growing and finishing pigs, and rarely affects other groups. As its name indicates, its clinical presentation is through skin lesions and affects the kidneys. Possibly the clinical signs appear eventually in a small number of animals. Mortality of affected pigs is almost 100%.
Symptoms
Sows and lactating piglets
Weaners and growers
Causes / contributing factors
Diagnosis
Control / prevention
This article describes the main characteristics of commercial vaccines to combat swine circovirosis.
Hans Nauwynck defines himself as a veterinary virologist, a person who works in a laboratory setting, doing precise work, like a surgeon, aiming to gain a better understanding of how animal viruses interact with their target cells. But it is much more. His deep understanding of the biological behavior of viruses allows him to fluently explain many of the “whys” that are so important for a better understading of the pathogenesis of viral diseases and the development of effective control strategies.
Professor Nauwynck has been researching PCV2 virus since the emergence of PCV2-associated diseases. PCV2 caused a serious crisis in global swine health that was ultimately addressed through the development and mass deployment of effective PCV2 vaccines. He is an excellent connoisseur of this small virus that continues to surprise us.
In healthy animals, PCV2 stays under the radar, causing little harm. But with coinfections that activate the immune system, the virus replicates more and becomes more damaging.